Cancer drugs approved on the basis of a surrogate end point and subsequent overall survival: An analysis of 5 years of us food and drug administration approvals

Chul Kim; Vinay Prasad

doi:10.1001/jamainternmed.2015.5868

Cancer drugs approved on the basis of a surrogate end point and subsequent overall survival: An analysis of 5 years of us food and drug administration approvals

Chul Kim, Vinay Prasad

Knight Cancer Institute

Research output: Contribution to journal › Letter › peer-review

286 Scopus citations

Original language	English (US)
Pages (from-to)	1992-1994
Number of pages	3
Journal	JAMA internal medicine
Volume	175
Issue number	12
DOIs	https://doi.org/10.1001/jamainternmed.2015.5868
State	Published - Dec 2015

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1001/jamainternmed.2015.5868

Cite this

@article{c6b8448411c8437ba7b10d6ee0ca9644,

title = "Cancer drugs approved on the basis of a surrogate end point and subsequent overall survival: An analysis of 5 years of us food and drug administration approvals",

author = "Chul Kim and Vinay Prasad",

year = "2015",

month = dec,

doi = "10.1001/jamainternmed.2015.5868",

language = "English (US)",

volume = "175",

pages = "1992--1994",

journal = "JAMA internal medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Cancer drugs approved on the basis of a surrogate end point and subsequent overall survival

T2 - An analysis of 5 years of us food and drug administration approvals

AU - Kim, Chul

AU - Prasad, Vinay

PY - 2015/12

Y1 - 2015/12

UR - http://www.scopus.com/inward/record.url?scp=84964837459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964837459&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2015.5868

DO - 10.1001/jamainternmed.2015.5868

M3 - Letter

C2 - 26502403

AN - SCOPUS:84964837459

SN - 2168-6106

VL - 175

SP - 1992

EP - 1994

JO - JAMA internal medicine

JF - JAMA internal medicine

IS - 12

ER -

Cancer drugs approved on the basis of a surrogate end point and subsequent overall survival: An analysis of 5 years of us food and drug administration approvals

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this